WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Disease and Therapy Review: Migraine

Timely Data Resources, Inc, September 2012, Pages: 13

The Migraine Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the migraine market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.

The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. OVERVIEW
General description of the condition
Types of migraines

II. PREVALENCE
Prevalence Table (Canada, US, Brazil, France, Germany, Greece Italy, Poland, Romania, Russia, Spain, Sweden, UK, China, Georgia, Japan, Europe, Worldwide)

III. DIAGNOSIS
Diagnostic criteria

IV. TREATMENT
Prophylactic therapy
Dosing and side effects for commonly used prophylactic treatments
Symptomatic therapy
Dosing for commonly used symptomatic treatments
Treatment of cluster headaches

X. TREATMENT COSTS
Costs for commonly prescribed non-generic drugs

XI. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

XII. COMMENTS

XIII. REFERENCES/RESOURCES

Customers who bought this item also bought